Doug Langa joined Novo Nordisk in 2011 as senior director, Managed
Markets. In 2015, Mr Langa was promoted to Corporate Vice president of
Market Access in the US and in 2016 he was appointed Senior Vice
President of Market Access in the US. In this role he was responsible
for securing formulary access with key payer customers for Novo
Nordisk brands. In March 2017, Mr Langa was appointed senior vice
president, head of North America Operations and president of Novo
Nordisk Inc., and in August 2017 Mr Langa was promoted to executive
vice president, continuing his responsibilities as head of North
America Operations and president of Novo Nordisk Inc.
Mr Langa joined Novo Nordisk from GlaxoSmithKline, where he was the Senior Director of Payer Marketing. Prior to GlaxoSmithKline, Mr Langa spent the majority of his career at Johnson and Johnson, where he held various roles of increasing responsibility within Managed Markets, Sales Leadership and Marketing. Mr. Langa has over 25 years of experience in the pharmaceutical and medical device industry.
Mr Langa graduated from Widener University, US, in 1989 and has an MBA from Fordham University, US, from 1997.
Mr Langa is a US national, born October 1966.